18 Hrs_1777294237270_124456903.png&w=48&q=75)
Source:
الوطن
Electronic tracking violations raise penalty costs for pharma
The General Food and Drug Authority provided clarification regarding violations by 17 pharmaceutical establishments during May, June, and July 2026. Their total fines amounted to 1,575,340 SAR due to non-compliance with the electronic tracking system for pharmaceutical products, "Rasad." The violations included failure to report medication movements directly, not maintaining a stock sufficient for six months, not replenishing shortages within three months, and failing to provide prior notification of supply shortages or interruptions at least six months in advance. The "Rasad" system aims to track medicines from manufacturing to the consumer, enhance drug security, and reduce counterfeit products. Penalties can reach up to 5 million SAR or temporary closure of hospitals for up to 180 days.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)